Sector: Pharmaceuticals

Latest content

Sweden

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

In Sweden, pharmaceutical trademarks are governed by trademark law and also, to some extent, by sector-specific regulation. Primarily, the bodies dealing with the registration of pharmaceutical trademarks are those involved in granting registrations for all kinds of trademark.

22 September 2010

Poland

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

The Pharmaceutical Law is almost entirely based on the principles of EU law. All Community regulations and judgments of the Court of Justice of the European Union relating to pharmaceutical issues – including trademarks, repackaging and parallel imports – are directly applicable in Poland.

22 September 2010

United States

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

The drug naming process comprises three components: the chemical name for the molecular structure of a drug, its generic name and its brand name. The reason for having both a generic name and a brand name is because a generic name may be used by all who wish to refer to this substance, whereas a brand name is owned by the firm that markets that drug.

22 September 2010

Foreword

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

It is a pleasure to welcome you to the second edition of Pharmaceutical Trademarks – A Global Guide. Building on the success of the inaugural edition, Pharmaceutical Trademarks 2010/2011 provides trademark professionals with comprehensive guidance on the key issues involved in the protection, enforcement and marketing of pharmaceutical brands. Written by experts from leading firms across the globe, the guide is designed to help the busy practitioner to make an international comparison of the practices and procedures governing pharmaceutical marks. To achieve this, this year’s edition presents analysis from 18 key jurisdictions, with a regional chapter investigating the particular challenges arising from similarities between pharmaceutical trademarks in the European Union. Although the chapters in this book offer valuable insight on law and practice governing pharmaceutical trademarks, they do not seek to provide specific legal advice and should not be read as such. However, only those firms and organisations with specialist expertise in the field of pharmaceutical trademarks were invited to contribute, and the authors raise a number of critical points that rights holders and their advisers should take into consideration when constructing an international pharmaceutical protection strategy. I am grateful to all of the authors for their commitment to and participation in this valuable project, and would also like to thank the Pharmaceutical Trade Marks Group for all its assistance during the production of Pharmaceutical Trademarks 2010/2011.Trevor LittleManaging editor

22 September 2010

Indonesia

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

Indonesia’s rapidly growing domestic market presents significant opportunities for pharmaceutical companies seeking to do business in the country. However, its geography and unique socioeconomic conditions also present a challenge. Success is possible through a robust strategy, as well as strict and transparent compliance with Indonesia’s regulatory regime.

22 September 2010

The Pharmaceutical Trade Marks Group – defining an industry role

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

There is a considerable history behind the Pharmaceutical Trade Marks Group (PTMG) and some major traditions to be upheld. Reflecting the pace of change in the pharmaceutical trademark sector and the challenges facing trademark counsel, the PTMG cannot stand still, but needs to progress, learn, grow and develop. The PTMG has to manage change and rise to new challenges, while at the same time remaining true to its essential nature.

22 September 2010

Japan

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

Under the Pharmaceutical Affairs Law, sellers must obtain approval from either the Ministry of Health, Labour and Welfare or the prefecture in order to market pharmaceutical products, including drugs (defined in Article 2(1) of the law). Approval must be obtained for each product.

22 September 2010

Vietnam

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

Vietnam is one of the fastest-growing markets in the global healthcare industry. According to a 2009 report published by Business Monitoring International Ltd, there are approximately 57,000 pharmacies in Vietnam, equating to 6.6 outlets per 1,000 people – a high figure for a developing country.

22 September 2010

Mexico

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

Trademarks in Mexico are regulated under the Industrial Property Law and its regulations. Industrialists, merchants and service providers can use trademarks in industry and commerce, or for the services that they provide (Article 87 of the law). The exclusive right to use a trademark is obtained by registering the mark with the Trademark Office.

22 September 2010

Luxembourg

Featured in Pharmaceutical Trademarks 2010 - A Global Guide

Pharmaceutical trademarks are regulated by the general trademark legislation – namely, the 2006 Law Approving the Benelux Convention on Intellectual Property – and by national legislation on medicines and IP rights.

22 September 2010

Unlock unlimited access to all WTR content